0 of 5 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 5 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. Please list your last name and zip code:
2. What is your specialty?
3. How many patients with IBD do you see each week?
4. The results of the PIANO study (Pregnancy and Neonatal Outcomes after Fetal Exposure to Biologics and Thiopurines among Women with Inflammatory Bowel Disease) showed which of the following infant outcomes regarding IBD therapies taken during pregnancy?
5. Your patient, a 25-year-old female in remission on adalimumab, presents to the clinic to discuss pregnancy planning. She researched “biologics and pregnancy” and she understands that biologics cross the placenta during pregnancy and that the infant will have measurable levels of the drug at birth and for several months. She is very concerned about how this can affect the infant in terms of risk of infections and development in the first year of life. Based on the PIANO results, which of the following pieces of information can you provide?